KERX SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Keryx B...
August 31 2016 - 10:09AM
Business Wire
The Law Offices of Vincent Wong announce that a class action
lawsuit has been commenced in the USDC for the Southern District of
New York on behalf of investors who purchased Keryx
Biopharmaceuticals, Inc. (NASDAQ:KERX) securities February 25,
2016 and August 1, 2016.
Click here to learn about the case:
http://www.wongesq.com/pslra/keryx-biopharmaceuticals. There
is no cost or obligation to you.
According to the complaint, throughout the Class Period,
Defendants made materially false and/or misleading statements, as
well as failed to disclose material adverse facts about the
Company’s business, operations, and prospects. Specifically,
Defendants made false and/or misleading statements and/or failed to
disclose: (1) that the Company was experiencing production-related
difficulties in converting API to finished drug product; (2) that
the issue was resulting in decreased production yields of finished
drug product; (3) that, as a result, the Company would, and did
exhaust its reserve of finished drug product; and (4) that, as a
result of the foregoing, Defendants’ statements about Keryx’s
business, operations, and prospects, were false and misleading
and/or lacked a reasonable basis.
If you suffered a loss in Keryx Biopharmaceuticals you have
until October 3, 2016 to request that the Court appoint you as lead
plaintiff. Your ability to share in any recovery doesn’t require
that you serve as a lead plaintiff. To obtain additional
information, contact Vincent Wong, Esq. either via email
vw@wongesq.com, by telephone at 212.425.1140, or visit
http://www.wongesq.com/pslra/keryx-biopharmaceuticals.
Vincent Wong, Esq. is an experienced attorney that has
represented investors in securities litigations involving financial
fraud and violations of shareholder rights. Attorney advertising.
Prior results do not guarantee similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160831005929/en/
The Law Offices of Vincent WongVincent Wong, Esq.,
212-425-1140Fax. 866-699-3880E-Mail: vw@wongesq.com
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From Sep 2023 to Sep 2024